Mereo BioPharma Group plc
Pharmaceutical Preparations · LONDON
Moderate confidence (50%)
Updated Oct 18, 2026, 12:03 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Mereo BioPharma Group plc received a delisting notice from its exchange (Aug 18, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Mereo BioPharma Group plc received a delisting notice from its exchange
Aug 18, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 - Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing As previously disclosed, on February 17, 2026, Mereo BioPharma Group plc (the Company ) received a written notice (the First Notice ) from the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) indicating that it no longer met the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market (the Capital Market ) under Nasdaq Listing Rule 5550(a)(2) (the Bid Price Requirement ). In accordance wi…”
Mereo BioPharma Group plc received a delisting notice from its exchange
Feb 17, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 - Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On February 17, 2026, Mereo BioPharma Group plc (the Company ) received a letter (the Notification Letter ) from the Listings Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that its American Depositary Shares ( ADSs ) failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the Bid Price Requirement ). Th…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker MREO on Nasdaq.
- SEC CIK
- 0001719714
- Website
- —
- —
- Headquarters
- LONDON
- Also known as
- —
- Legal entities
- Mereo BioPharma Group plc
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Mereo BioPharma Group plc — Pharmaceutical Preparations (SIC 2834) — LONDON
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 - Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On February 17, 2026, Mereo BioPharma Group plc (the Company ) received a letter (the Notification Letter ) from the Listings Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that its American Depositary Shares ( ADSs ) failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the Bid Price Requirement ). Th…
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 - Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing As previously disclosed, on February 17, 2026, Mereo BioPharma Group plc (the Company ) received a written notice (the First Notice ) from the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) indicating that it no longer met the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market (the Capital Market ) under Nasdaq Listing Rule 5550(a)(2) (the Bid Price Requirement ). In accordance wi…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:11 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 12:09 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:36 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.